HuD has been reported to increase in the brain of AD patients and to stabilize APP mRNA, β-site APP-cleaving enzyme 1 (BACE1) mRNA, and BACE1 antisense (BACE1-AS) lncRNAs, thereby facilitating the accumulation of the toxic APP cleavage product Aβ [168]. This evidence concerns the gene APP and Alzheimer disease.